Autism Spectrum Disorders Research Center, Hamadan University of Medical Sciences, Hamadan 6517838687, Iran.
Mental Health Research Center, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran 1449614535, Iran.
Int J Environ Res Public Health. 2021 Aug 14;18(16):8582. doi: 10.3390/ijerph18168582.
Brief cognitive screening instruments are used to identify patients presenting with cognitive symptoms that warrant further assessment. This study aimed to evaluate the reliability and validity of the Persian version of the Quick Mild Cognitive Impairment (Q-Pr) among middle-aged and older Iranian adults. Consecutive patients aged ≥55 years and caregivers attending with them as normal controls (NCs) were recruited from geriatric outpatient clinics and a hospital in Tehran, Iran. All patients completed the Q-Pr before completing an independent detailed neuropsychological assessment and staging using the Clinical Dementia Rating (CDR) Scale. NCs underwent the same assessment. In all, 92 participants with a median age of 70 years (±13) were available. Of these, 20 participants were NCs, 24 had subjective memory complaints (SMC), 24 had mild cognitive impairment (MCI), and 24 had Alzheimer's disease (AD). The Q-Pr had good accuracy in differentiating SMC and NC from MCI (area under the curve (AUC): 0.80 (0.69-0.91)) and in identifying cognitive impairment (MCI and mild AD) (AUC: 0.87 (0.80-0.95)) with a sensitivity of 88% and specificity of 80%, at an optimal cut-off of <53/100. The Q-Pr is an accurate short cognitive screening impairment for separating NC and patients with SMC from MCI and identifying cognitive impairment. Further research with larger samples and comparison with other widely used instruments such as the Montreal Cognitive Assessment is needed. Given its established brevity, the Q-Pr is a useful screen for Iranian adults across the spectrum of cognitive decline.
简短的认知筛查工具用于识别出现认知症状的患者,这些症状需要进一步评估。本研究旨在评估波斯语版快速轻度认知障碍(Q-Pr)在伊朗中老年成年人中的可靠性和有效性。连续≥55 岁的患者及其作为正常对照(NC)的照顾者从老年门诊和伊朗德黑兰的一家医院招募。所有患者在接受独立的详细神经心理学评估和使用临床痴呆评定量表(CDR)进行分期之前都完成了 Q-Pr。NC 接受了相同的评估。共有 92 名参与者,中位年龄为 70 岁(±13)。其中,20 名参与者为 NC,24 名参与者有主观记忆抱怨(SMC),24 名参与者有轻度认知障碍(MCI),24 名参与者有阿尔茨海默病(AD)。Q-Pr 在区分 SMC 和 NC 与 MCI(曲线下面积(AUC):0.80(0.69-0.91))和识别认知障碍(MCI 和轻度 AD)(AUC:0.87(0.80-0.95))方面具有良好的准确性,敏感性为 88%,特异性为 80%,最佳截断值为<53/100。Q-Pr 是一种准确的简短认知筛查工具,用于区分 NC 和 SMC 患者与 MCI,并识别认知障碍。需要进一步进行更大样本量的研究,并与其他广泛使用的工具(如蒙特利尔认知评估)进行比较。鉴于其已确立的简短性,Q-Pr 是伊朗成年人在认知衰退谱上的有用筛查工具。